Tevogen Bio Holdings Inc Sustainability Reports
Clinical-stage specialty immunotherapy company developing off-the-shelf, genetically unmodified T cell therapies (ExacTcell platform) for cancers, viral infections, and neurological disorders.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
1 reports from 2025 to 2025
Company Profile
Clinical-stage specialty immunotherapy company developing off-the-shelf, genetically unmodified T cell therapies (ExacTcell platform) for cancers, viral infections, and neurological disorders.
Reports
1 total
Limited sustainability disclosure available
The reports currently shown are annual reports without dedicated sustainability sections.
Years
